SCHEMBL20547359

SCHEMBL20547359

CCOC(=O)N1CCc2noc(-c3cccc(C)c3)c2CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.48
CYP3A4 P08684 2/20 0.46
GRM5 P41594 2/20 0.46
CYP1A2 P05177 1/20 0.46
KCNH2 Q12809 1/20 0.46
KMT2A Q03164 3/20 0.45
ALDH1A1 P00352 2/20 0.45
LMNA P02545 4/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
GLA P06280 1/20 0.43
MAPK1 P28482 1/20 0.43
MEN1 O00255 2/20 0.42
ATM Q13315 2/20 0.42
PABPC1 P11940 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547285 0.89 KCNH2 (0.56) CYP3A4GRM5CYP1A2KCNH2KMT2A
SCHEMBL20547288 0.89 LMNA (0.50) CYP3A4GRM5KCNH2KMT2AALDH1A1
SCHEMBL20547218 0.89 KMT2A (0.51) KMT2AALDH1A1LMNAMAPTTSHR
SCHEMBL20546709 0.86 LMNA (0.51) CYP1A2KMT2AALDH1A1LMNAMAPT
SCHEMBL20547217 0.82 LMNA (0.47) CYP3A4CYP1A2KCNH2KMT2ALMNA
SCHEMBL20547362 0.82 SMN1; SMN2 (0.53) CYP3A4CYP1A2KCNH2KMT2AALDH1A1
SCHEMBL20547293 0.80 NPC1 (0.54) KMT2AALDH1A1LMNAMAPTTSHR
SCHEMBL20547245 0.78 NPC1 (0.53) CYP3A4CYP1A2KCNH2KMT2AALDH1A1
SCHEMBL20547246 0.78 NPC1 (0.53) KMT2AALDH1A1LMNAMAPTTSHR
SCHEMBL5958562 0.72 KMT2A (0.58) DPP4CYP1A2KCNH2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560927-B1 AZEPINE DERIVATIVES ACTING AS 5-HT7 RECEPTOR MODULATORS KOREA INST SCI & TECH (KR) 2023-04-19 EP disclosed
EP-3560927-A1 AZEPINE DERIVATIVE ACTING AS 5-HT7 RECEPTOR MODULATOR Korea Institute of Science and Technology (KR) 2019-10-30 EP disclosed
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2019-10-08 US disclosed
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS HTR7, HTR5A, HTR3A DPP4 1581/4885CYP3A4 800/4885GRM5 31/4885
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators HTR7, HTR5A, HTR3A DPP4 1581/4885CYP3A4 800/4885GRM5 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.